Balancing The Need For Complete Characterization Of Protein-Protein Interactions
Source: Soluble Therapeutics
Protein formulation is becoming increasingly complex due to the complexity of the biomolecules to be formulated and regulatory necessities in the process. Drug product development researchers need reliable data on how the formulation of their biologics can impact potential aggregation, physical/chemical instability, and viscosity issues before proceeding too far down the development road. This paper looks at both Kd and B22 as predictors of formulation success, and potential drawbacks of each."
access the White Paper!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.
Subscribe to Bioprocess Online
X
Subscribe to Bioprocess Online
This website uses cookies to ensure you get the best experience on our website. Learn more